Champions Oncology CSBR
NASDAQ CSBR
$4.83 -0.07 (-1.43%)
As of: Oct 14, 2026 · 1:25 PM EDT

Champions Oncology (CSBR) Depreciation & Amortization (CF) (2010 - 2026)

Updated

Champions Oncology's Depreciation & Amortization (CF) came in at $314,000 for fiscal Q1 2027 (quarter ended Jul 31, 2026), down 12.3% from $358,000 a year earlier and down 2.2% from the prior quarter.

Analysis

Champions Oncology (CSBR) Depreciation & Amortization (CF) (2010 - 2026) Analysis & Trends

Over the trailing twelve months to Jul 31, 2026, Champions Oncology reported Depreciation & Amortization (CF) of $1.33 million, down 13.9% year-over-year; for FY2026 (ended Apr 30, 2026), it was $1.38 million, down 16.0% from FY2025.

  • Depreciation & Amortization (CF) has declined in each of the last three fiscal years, though with a five-year compound annual growth rate of 3.1% (FY2021 to FY2026).
  • Going back by fiscal year, Depreciation & Amortization (CF) was $1.64 million in FY2025 (-12.2%), $1.87 million in FY2024 (-16.9%), $2.25 million in FY2023 (+38.0%) and $1.63 million in FY2022 (+37.4%).
  • The fiscal Q1 2027 figure represents the lowest quarterly Depreciation & Amortization (CF) since fiscal Q4 2021.
  • Year-over-year, Depreciation & Amortization (CF) has declined for eight consecutive quarters, with an average decline of 15.6% over the last eight quarters.
  • The fastest year-over-year change in Depreciation & Amortization (CF) over five years came in fiscal Q4 2022 (growth of 87.5%), and the weakest in fiscal Q4 2024 (a decline of 21.6%).
  • Business Quant data shows CSBR's Depreciation & Amortization (CF) at $321,000 (Q4 2026), $341,000 (Q3 2026) and $357,000 (Q2 2026) in the three fiscal quarters before Q1 2027.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Iqvia Holdings 43.55 Bn 35.26 Bn 1.44 Bn 292.00 Mn
2 Medpace Holdings 17.34 Bn 15.40 Bn 201.64 Mn 6.56 Mn
3 Charles River Laboratories International 14.61 Bn 13.81 Bn 363.37 Mn 67.29 Mn
4 Icon 13.23 Bn 10.34 Bn 479.29 Mn 90.77 Mn
5 Fortrea Holdings 2.05 Bn 1.43 Bn 139.20 Mn 19.60 Mn
6 Ginkgo Bioworks Holdings 726.50 Mn -35.58 Mn 18.44 Mn 12.32 Mn
7 Evotec SE 504.32 Mn -1.11 Bn - -
8 Champions Oncology 67.13 Mn 42.21 Mn 7.70 Mn 314,000.00
9 MindWalk Holdings 65.40 Mn 29.05 Mn 1.61 Mn 190,775.50
10 Natural Alternatives International 6.57 Mn -21.51 Mn 1.73 Mn 1.18 Mn
Historic Data

Historic Data

Download Data
DateValue
Jul 31, 2026 314,000.00
Apr 30, 2026 321,000.00
Jan 31, 2026 341,000.00
Oct 31, 2025 357,000.00
Jul 31, 2025 358,000.00
Apr 30, 2025 394,000.00
Jan 31, 2025 398,000.00
Oct 31, 2024 399,000.00
Jul 31, 2024 449,000.00
Apr 30, 2024 457,000.00
Jan 31, 2024 481,000.00
Oct 31, 2023 484,000.00
Jul 31, 2023 445,000.00
Apr 30, 2023 583,000.00
Jan 31, 2023 575,000.00
Oct 31, 2022 560,000.00
Jul 31, 2022 528,000.00
Apr 30, 2022 568,000.00
Jan 31, 2022 396,000.00
Oct 31, 2021 346,000.00
API Access

Champions Oncology Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=CSBR&period=max&api_key=YOUR_API_KEY